Jaswant Singh Khera
Direktor/Vorstandsmitglied bei WEP Group Holdings Ltd.
Profil
Jaswant Singh Khera has held director positions at WEP Group Holdings Ltd.
and WE Pharma Ltd.
His current job(s) include being a Director at WEP Group Holdings Ltd.
and WE Pharma Ltd.
Aktive Positionen von Jaswant Singh Khera
Unternehmen | Position | Beginn |
---|---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Direktor/Vorstandsmitglied | 19.12.2017 |
WE Pharma Ltd.
WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |
WE Pharma Ltd.
WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |